Wednesday, March 12, 2025
HomeIndustries

Industries

IASO Bio’s Nanjing Manufacturing Facility Granted the Drug Manufacturing License for CAR-T Cell Therapy Products

IASO Biotherapeutics, a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative cell therapies and antibody products announced that the company's commercial manufacturing...

Antengene Announces XPOVIO® Regulatory Approval in Singapore

Antengene Corporation Limited, a leading innovative, global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer and other life-threatening...

InnoCare Announces Approval of Phase II Clinical Trial Using Orelabrutinib for the Treatment of NMOSD in China

InnoCare Pharma, a leading biopharmaceutical company, announced the Investigational New Drug (IND) approval of its Bruton's tyrosine kinase (BTK) inhibitor orelabrutinib by China National...

CORRECTING and REPLACING Strategic Retail Partners (SRP) Announces Asset Purchase of MobilEssentials

Strategic Retail Partners (SRP), a portfolio company of Aurora Capital Partners and leading North American category manager and solutions provider to more than 70,000...

East Point Energy Sells 100 Megawatt Energy Storage Project to Aypa Power

East Point Energy, a leading energy storage developer, announced the sale of the Yadkins Energy Storage project to Aypa Power, a Blackstone portfolio company...
0FansLike
0FollowersFollow
spot_img

Hot Topics